TipRanks
Advertisement

ETHO - ETF AI Analysis

Compare

Top Page

ETHO

Etho Climate Leadership U.S. ETF (ETHO)

Rating:69Neutral
Price Target:―
ETHO, the Etho Climate Leadership U.S. ETF, has a solid overall rating driven by strong, growing tech and healthcare names like Datadog, Okta, Corcept Therapeutics, and Pure Storage, which show healthy financial performance, positive earnings commentary, and strategic positioning in areas like AI and security. However, weaker holdings such as SELLAS Life Sciences and Personalis, which face significant financial and profitability challenges, hold back the fund’s rating somewhat. The main risk factor is the fund’s meaningful exposure to higher-valuation, momentum-driven tech and life sciences stocks, which can be more volatile and sensitive to changes in market sentiment.
Positive Factors
Broad Sector Diversification
The ETF spreads its investments across many sectors, including technology, industrials, financials, and health care, which helps reduce the impact if any one industry struggles.
Strong Recent Performance
The fund has shown strong gains so far this year and in recent months, indicating solid recent momentum.
Multiple Strong-Performing Top Holdings
Several of the largest positions, such as Maxlinear and Aehr Test Systems, have delivered strong year-to-date gains, supporting the ETF’s overall results.
Negative Factors
Higher Expense Ratio
The fund’s expense ratio is on the higher side for an ETF, which means more of the returns are used to cover fees.
Heavy U.S. Concentration
With almost all assets invested in U.S. companies, the ETF offers little geographic diversification and is highly tied to the U.S. market.
Tilt Toward Technology and Health Care
A relatively large allocation to technology and health care stocks increases the fund’s sensitivity to swings in these often more volatile sectors.

ETHO vs. SPDR S&P 500 ETF (SPY)

ETHO Summary

The Etho Climate Leadership U.S. ETF (ETHO) is a fund that tracks the Etho Climate Leadership Index, focusing on U.S. companies that are leaders in cutting their carbon emissions and following strong environmental practices. It holds a mix of sectors like technology, industrials, and health care, with names such as Datadog and Okta among its top positions. Someone might invest in ETHO to seek long-term growth while supporting cleaner, lower-carbon businesses and getting broad diversification across many industries. A key risk is that the ETF still moves with the overall stock market, so its value can go up and down over time.
How much will it cost me?The Etho Climate Leadership U.S. ETF (ETHO) has an expense ratio of 0.45%, meaning you’ll pay $4.50 per year for every $1,000 invested. This is higher than average for ETFs because it is actively managed to focus on companies with strong environmental leadership and low-carbon impact. The higher cost reflects the specialized research and curation involved in maintaining its ESG standards.
What would affect this ETF?The ETHO ETF, with its focus on U.S. companies committed to reducing carbon emissions, could benefit from growing interest in sustainable investing and potential government incentives for green technologies. However, it may face challenges from economic downturns that impact its key sectors like technology and consumer cyclical, or regulatory changes affecting ESG-focused investments.

ETHO Top 10 Holdings

ETHO leans heavily into U.S. tech and health care names, with rising software and data players like Datadog, Okta, Semtech, and Pure Storage helping power returns and giving the fund a clear innovation tilt. On the flip side, smaller positions in MaxLinear, Personalis, and SELLAS Life Sciences bring more mixed or lagging performance, reflecting ongoing profitability and financing challenges. Overall, the ETF is broadly diversified across U.S. sectors but still tells a clear story: climate-conscious investors are riding a wave of low-carbon, high-growth tech and biotech leaders.
Name
Company Name
Weight %
Market Value
Market Cap
Yearly Gain
Overall Rating
Maxlinear1.58%$3.04M$8.72B571.04%
60
Neutral
10x Genomics1.07%$2.06M$10.51B603.14%
60
Neutral
Corcept Therapeutics0.87%$1.67M$13.10B63.86%
76
Outperform
Okta0.82%$1.58M$40.58B159.80%
75
Outperform
SELLAS Life Sciences Group0.78%$1.50M$2.35B509.95%
43
Neutral
Repligen0.77%$1.49M$11.04B19.72%
68
Neutral
Everpure0.75%$1.44M$51.48B72.86%
64
Neutral
Personalis0.74%$1.43M$1.71B97.04%
49
Neutral
Semtech0.71%$1.37M$17.48B187.00%
69
Neutral
Aehr Test Systems0.69%$1.33M$2.76B260.32%
55
Neutral

ETHO Technical Analysis

Technical Analysis Sentiment
Neutral
Last Price―
Price Trends
50DMA
81.03
Negative
100DMA
79.45
Positive
200DMA
74.38
Positive
Market Momentum
MACD
0.04
Negative
RSI
49.46
Neutral
STOCH
43.36
Neutral
Evaluating momentum and price trends is crucial in ETF analysis to make informed investment decisions. For ETHO, the sentiment is Neutral. The current price of undefined is equal to the 20-day moving average (MA) of 80.09, equal to the 50-day MA of 81.03, and equal to the 200-day MA of 74.38, indicating a neutral trend. The MACD of 0.04 indicates Negative momentum. The RSI at 49.46 is Neutral, neither overbought nor oversold. The STOCH value of 43.36 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Neutral sentiment for ETHO.

ETHO Peer Comparison

Comparison Results
Name
Price
Price Target
AUM
Expense Ratio
Overall Rating
――$192.55M0.45%
69
Neutral
――$923.27M0.69%
67
Neutral
――$890.75M0.30%
65
Neutral
――$744.24M0.65%
72
Outperform
――$544.05M0.60%
74
Outperform
――$302.73M0.10%
74
Outperform
Performance Comparison
Ticker
Company Name
Price
Change
% Change
ETHO
Etho Climate Leadership U.S. ETF
80.30
17.01
26.88%
AIPO
Defiance AI & Power Infrastructure ETF
―
―
―
UFOX
Defiance Connective Technologies Etf
―
―
―
FEPI
REX FANG & Innovation Equity Premium Income ETF
―
―
―
PNQI
Invesco NASDAQ Internet ETF
―
―
―
USNZ
Xtrackers Net Zero Pathway Paris Aligned US Equity ETF
―
―
―
Glossary
BuyAn ETF rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF is likely to deliver higher returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldAn ETF rated as a "Hold" s expected to perform in line with the overall market or a specific benchmark. This rating indicates that the ETF is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellAn ETF rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF may deliver lower returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
DisclaimerThis AI Analyst ETF Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in ETFs carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: ―
Table of Contents
Advertisement